{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/65a03aa060fa410017350088?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio ","description":"<p>Episode 4 (January 12, 2024): Takeaways from the J.P. Morgan Health Care conference: Illumina, Danaher, 10x, Empress Therapeutics; an interview with Liberate Bio’s Shawn Davis and Walter Strapps.&nbsp;</p><p><br></p><p>Listed below are references to relevant <em>GEN</em> stories discussed in this episode of <em>Touching Base</em>:&nbsp;</p><p><br></p><ul><li><a href=\"http://jpm:%20Illumina%E2%80%99s%20New%20CEO%20Spells%20Out%202024%20Priorities,%20Presents%20Preliminary%20Q4,%202023%20Results/\" rel=\"noopener noreferrer\" target=\"_blank\">JPM: Illumina’s new CEO spells out 2024 priorities, presents preliminary Q4 2023 results</a>&nbsp;</li></ul><p>By Alex Philippidis, GEN, January 10, 2024.&nbsp;</p><ul><li><a href=\"https://www.genengnews.com/topics/genome-editing/jpm-prime-medicine-eyes-2024-ind-for-first-prime-editing-therapy/\" rel=\"noopener noreferrer\" target=\"_blank\">JPM: Prime Medicine eyes 2024 IND for first prime editing therapy</a>&nbsp;</li></ul><p>By Alex Philippidis, GEN, January 9, 2024&nbsp;</p><ul><li><a href=\"https://www.genengnews.com/topics/cancer/jpm-2024-veracytes-c2i-genomics-acquisition-adds-ai-readouts-to-liquid-biopsy-testing/\" rel=\"noopener noreferrer\" target=\"_blank\">JPM 2024: Veracyte’s C2i genomics acquisition adds AI readouts to liquid biopsy testing</a>&nbsp;</li></ul><p>By Jonathan D. Grinstein, GEN, January 8, 2024&nbsp;</p><ul><li><a href=\"https://www.genengnews.com/industry-news/jpm-more-ma-firepower-in-store-for-2024-ey-predicts/\" rel=\"noopener noreferrer\" target=\"_blank\">JPM: More M&amp;A “firepower” in store for 2024, EY predicts</a>&nbsp;</li></ul><p>By Alex Philippidis, GEN, January 8, 2024&nbsp;</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}